Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × FED × avelumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 14 OTHER 5 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1

Interventions

poly ICLC 1 copanlisib 1 avelumab 1 Yoga 1 Immunoglobulins, Intravenous 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Celecoxib 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡